.jpg)
.png)
Summer 2023
“It is not the strongest of the species that survives, nor the most intelligent that survives. It is the one that is most adaptable to change, that lives within the means available, and works cooperatively against common threats”. - Charles Erasmus Darwin It is always my pleasure to... more
In this LipidSpin edition of the “NLA Impact on the Health Community”, we highlight how the NLA contributes to the understanding of incredibility impactful issues in medicine. The NLA has contributed to many aspects of clinical lipid medicine with scientific statements,... more
What is Lp(a) and Why Is It Important? In recent years, lipoprotein(a) [Lp(a)] has been recognized as a prevalent risk factor for cardiovascular disease. It is estimated that ~20% of the global population have elevated Lp(a) levels (greater than 50 mg/dL or 100 nmol/L). Lp(a) risk for major... more
Introduction As healthcare professionals, we devote our careers to service. We hope to make a lasting impact for each of our patients. Our advancements in treating and preventing cardiovascular disease over the past few decades have made a clear impact, one patient at a time. As a nation,... more
A medical specialist is a provider/clinician with expertise beyond the generalist. The National Lipid Association (NLA) partners with the American Board of Clinical Lipidology (ABCL) to recognize those who have additional experience and knowledge in lipidology. The ABCL offers the only... more
Introduction More than half of adults in the United States report taking dietary supplements.1 For example, some choose supplements in place of statins in hopes of lowering low density lipoprotein cholesterol (LDL-C) and consequently the risk of atherosclerotic cardiovascular disease (ASCVD).1... more
Heterozygous familial hypercholesterolemia (HeFH) is an autosomal co-dominant genetic disorder, affecting roughly 1 in 220 people; characterized by lifelong elevated levels of LDL cholesterol (LDL-C) and thus predisposing to development of premature atherosclerotic cardiovascular disease (ASCVD).1-... more
History We recently celebrated the twentieth anniversary of the NLA in 2022. It seems appropriate, when considering the impact of the NLA on the healthcare community, to reflect upon the environment in which the NLA was conceived, fostered, and evolved. In 1987 we started a lipid... more
Introduction Atherosclerotic cardiovascular disease (ASCVD) is an umbrella term for atherosclerotic conditions that affect the cardiovascular system, including ischemic heart disease, peripheral artery disease, and ischemic stroke. The public health impact of ASCVD is hard to overstate, it is... more